Loading decisions…
Loading decisions…
53,738 vetted Board decisions for Diabetes.
The Veteran's TDIU rating is granted effective July 10, 2007. The right and left shoulder adhesive capsulitis cases are remanded for further development.
The Board has vacated the May 16, 2022 decision and remanded the service connection issues for diabetes mellitus, type II, hypertension, heart disability, and respiratory disability. The claims are now being addressed based on new evidence.
The Veteran's appeals for earlier effective dates for service connection and SMC were denied. The earliest possible effective dates are January 27, 2017.
The Board is remanding all claims on appeal due to the need for VA examinations and opinions regarding frostbite residuals of various body parts.,The Board is also remanding the diabetes mellitus, hemorrhoids, and body rashes claims due to the need for verification of herbicide exposure during service in Korea.,PTSD, anxiety, nightmares, and hallucinations claims are being remanded without further action as there are no STRs available.
The Board has found that the Veteran's service connection claims for hepatocellular carcinoma, coronary artery disease, diabetes mellitus type II, hypertension, diabetic nephropathy, obstructive sleep apnea, iron deficiency anemia, and erectile dysfunction are remanded due to a failure to verify the Veteran's exposure to herbicide agents while stationed in Korea.
The Board has determined that there was a pre-decisional duty to assist error and remanded the claims for service connection for diabetes mellitus type II as secondary to PTSD and sleep apnea as secondary to PTSD. The Veteran's appeal is being remanded to correct this error.
The Veteran's diabetes mellitus, type II is granted as presumptively service connected due to presumed exposure to herbicide agents in Vietnam.
The Board has decided to remand the case due to deficiencies in the previous examination report, specifically regarding the secondary service connection for OSA. The Veteran's obesity is considered an intermediary factor between his service-connected disabilities and OSA.
The Board has determined that the Veteran's AIP and Type I Diabetes Mellitus were not caused or aggravated by VA care, specifically his Whipple procedure in August 2005. The decision is denied.
The Board has decided to remand the cases of increased rating for diabetes mellitus and TDIU due to a pre-decisional duty to assist error. The Veteran needs an additional VA examination to assess his type II diabetes mellitus, including any complications such as diabetic peripheral neuropathy.
The Board has remanded the Veteran's claim of service connection for diabetes, to include as secondary to exposure to toxic herbicides and/or jet fuel due to a lack of sufficient analysis in the previous decision. The AOJ is required to obtain further information regarding the Veteran's alleged exposures and provide an adequate medical opinion.
The Veteran's diabetes and hypertension are granted as presumptively related to exposure to herbicide agents during service in Korea. However, the claim for glaucoma is denied.,Service connection for hypertension is granted based on the presumption of herbicide agent exposure, effective from August 10, 2022 (PACT Act).,The Veteran's glaucoma is not found to be related to service or herbicide exposure.
The Board has remanded the claims for additional development due to a pre-decisional duty to assist error regarding Social Security Administration (SSA) records.
The Veteran's claims for service connection for diabetes mellitus and hand shaking were denied as there was no evidence linking these conditions to his military service.
The Board has denied service connection for diabetes mellitus and remanded the claims for sleep apnea (OSA) and neurocognitive disorder due to insufficient evidence.
The Veteran's appeals for service connection for left ear hearing loss and an initial compensable rating for right ear hearing loss have been dismissed.,The Veteran's appeal for service connection for diabetes has been granted, with the benefit of doubt being conferred in his favor.
The Veteran's claim for service connection for diabetes mellitus, type II was granted with an effective date of April 24, 2017.
The Veteran's bilateral lower extremity peripheral neuropathy is granted with a disability rating of 40 percent for each leg.,The Veteran's eye disability (cataracts) and headaches are remanded as the evidence is insufficient to determine their etiology.
The Board denied service connection for various conditions, including psychiatric disorders, bilateral leg swelling, diabetes mellitus, right knee and ankle pain, left hip pain, chronic back pain, hypertension, headaches, and prostate cancer. The evidence did not support a finding that these conditions were related to service or the presumption of herbicide exposure.
The Board has remanded the propriety of reducing a 100 percent disability rating for Rosai-Dorfman Disease after June 1, 2016 and the issues regarding higher ratings for left eye atrophy and blindness, diabetes insipidus, and seizure disorder as residuals of Rosai-Dorfman Disease. The remand requires an in-person VA examination to determine the current severity of the service-connected Rosai-Dorfman Disease.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.